A. Slot

发表

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

P. Koper, J. Lebesque, S. Peeters, 2005, International journal of radiation oncology, biology, physics.

Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.

P. Koper, J. Lebesque, S. Peeters, 2005, International journal of radiation oncology, biology, physics.

Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival.

J. Lebesque, A. Al-Mamgani, W. Heemsbergen, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

A. Stiggelbout, E. Schaake, J. Beukema, 2021, Gynecologic oncology.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.

P. Koper, W. van Putten, A. Slot, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.

J. Battermann, L. Blank, C. Koning, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Acute and late GI and GU toxicity after prostate irradiation to doses of 68 Gy and 78 Gy; results of a randomized trial

P. Koper, J. Lebesque, W. Putten, 2003 .

Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

J. Coebergh, E. Rutgers, H. Peterse, 1999, Cancer.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

H. Putter, W. V. Putten, R. Nout, 2010, The Lancet.

Less Gastrointestinal Toxicity After Adjuvant Radiotherapy on a Small Pelvic Field Compared to a Standard Pelvic Field in Patients With Endometrial Carcinoma

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2012, International Journal of Gynecologic Cancer.

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.

H. Putter, S. Oerlemans, E. M. van der Steen-Banasik, 2015, International journal of radiation oncology, biology, physics.

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.

H. Putter, L. V. van de Poll-Franse, E. M. van der Steen-Banasik, 2012, European journal of cancer.

Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship

H. Putter, S. Oerlemans, I. Jürgenliemk-Schulz, 2022 .

Update of the Results of the Dutch Multicenter Dose Escalation Trial of Radiotherapy for Localized Prostate Cancer

M. Hoogeman, J. Lebesque, A. Al-Mamgani, 2007 .

Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial

H. Putter, I. Jürgenliemk-Schulz, A. Slot, 2008 .

Abandonment of childhood cancer treatment in Western Kenya

P. M. van de Ven, G. Kaspers, A. Slot, 2014, Archives of Disease in Childhood.

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

H. Putter, T. Bosse, D. Cibula, 2020, International Journal of Gynecological Cancer.

Local recurrence after breast conservation therapy for early stage breast carcinoma

J. Coebergh, E. Rutgers, H. Peterse, 1999 .

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

Hein Putter, H. Putter, E. M. van der Steen-Banasik, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2019, The Lancet. Oncology.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2011, Obstetrics and gynecology international.

Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2007, International Journal of Gynecologic Cancer.

The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor.

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2010, Gynecologic oncology.

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Joos V Lebesque, Luca Incrocci, P. Koper, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.

E. M. van der Steen-Banasik, H. Westerveld, M. Nowee, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.

T. Bosse, V. Smit, H. Westerveld, 2018, Gynecologic oncology.

Cervical cancer metastasising to the breast: report of two cases.

T. Wiggers, B. van Ooijen, S. Henzen‐Logmans, 1993, The European journal of surgery = Acta chirurgica.

Adjuvant postoperative radiotherapy for gastric carcinoma with poor prognostic signs.

W. van Putten, A. Treurniet‐Donker, W. V. Putten, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

L. Collette, M. Bolla, J. Bosset, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Axial cortical involvement of metastatic lesions to identify impending femoral fractures; a clinical validation study.

E. Tanck, Y. M. van der Linden, N. Verdonschot, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands.

Jasper Nijkamp, Marcel B van Herk, Yvette van der Linden, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

5000 ORAL Quality of life after radiotherapy for endometrial cancer: first results from the randomized PORTEC-2 trial

H. Putter, R. Nout, A. Slot, 2007 .

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

J. Lebesque, A. Al-Mamgani, W. van Putten, 2008, International journal of radiation oncology, biology, physics.

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

L. Collette, P. Maingon, M. Bolla, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.

J. Burgerhof, K. Muller, J. Plukker, 2014 .

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

T. Bosse, B. van Triest, W. van Putten, 2018, British Journal of Cancer.

Two overlooked contributors to abandonment of childhood cancer treatment in Kenya: parents' social network and experiences with hospital retention policies

G. Kaspers, A. Slot, R. Vreeman, 2014, Psycho-oncology.

Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.

M. Hoogeman, P. Koper, J. Lebesque, 2005, International journal of radiation oncology, biology, physics.

Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.

J. Battermann, L. Blank, C. Koning, 2012 .

A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.

G. Hospers, J. Burgerhof, K. Muller, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

A. Slot, J. Jobsen, V. Smit, 2010, The Lancet.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

F. van Coevorden, K. Sikorska, J. V. van Sandick, 2018, The Lancet. Oncology.

UvA-DARE ( Digital Academic Repository ) ( Un-) certainties in radiotherapy of rectal cancer

C. Marijnen, H. Ceha, J. Beukema, 2012 .